 |
|
|
|
|
|
|
|
 |
Results for 'Assay Development and Technologies' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Third Wave Technologies, Inc. Product Pipeline Analysis
|
May 2008 |
£380 |
35 % |
Ion Channel Drug Discovery
Therapeutic Opportunities & Technology Progress
|
May 2004 |
£680 |
25.2 % |
Tissue Microarrays
Market Assessment and Opportunities
|
May 2004 |
£1995 |
21 % |
Promising Drug Discovery Tools in Antifungal & Status on Emerging Novel Targets
|
August 2004 |
£335 |
20.5 % |
The Future Of Array Technologies
Impact on drug discovery and market growth in DNA, protein and tissue arrays
|
January 2005 |
£1495 |
18.9 % |
Personalized Medicine
|
August 2007 |
£990 |
18.55 % |
Pharmacodiagnostics
Technologies, Competition, and Market Models
|
July 2005 |
£2340 |
18.2 % |
Drug Discovery Tools for High-Content Analysis
|
July 2007 |
£990 |
17.5 % |
Translational Medicine In Biopharmaceutical R&d
Enabling R&d Optimization And Early Detection Of Potential Failures
|
October 2007 |
£1495 |
16.1 % |
Toxicogenomics and Predictive Toxicology
|
December 2004 |
£1950 |
16.1 % |
Predictive ADME and Toxicology Strategies
Challenges and opportunities for in vivo, in vitro and in silico predictive technologies
|
January 2006 |
£1495 |
15.05 % |
Worldwide Cell Based Screening & Analysis Market for Bio-Pharma Drug Discovery
Equipment, Technologies and Companies, 2006-2011
|
January 2007 |
£815 |
15.05 % |
Outsourcing in Drug Discovery, 3rd Edition
|
May 2008 |
£1510 |
13.65 % |
Companion Diagnostics in Personalized Medicine and Cancer Therapy
|
April 2008 |
£1715 |
13.65 % |
Cytogenetics
Technologies, markets and companies
|
March 2008 |
£995 |
13.3 % |
Drug Discovery
Current trends and future prospects
|
February 2001 |
£300 |
12.6 % |
RNA Interference for Drug R&D
Applications, Alliances, Companies and WW Market to 2011
|
July 2007 |
£1290 |
11.55 % |
Pharmacogenomics: New Technologies
In the Development of Personalized Therapies
|
August 2005 |
£2255 |
11.55 % |
Gene Expression Reagents Markets
|
April 2007 |
£990 |
11.55 % |
New Concepts in Cancer Therapeutics
|
December 2005 |
£1665 |
11.55 % |
SNP Genotyping and Analysis Markets
|
June 2008 |
£2015 |
11.55 % |
Cell-Based Diagnostics: Technology, Applications, and Markets
2nd Edition
|
November 2007 |
£2015 |
10.85 % |
ADME/TOX Technologies
|
January 2008 |
£1450 |
10.85 % |
The Market for In Vitro Toxicology Testing
|
March 2007 |
£2410 |
10.5 % |
Labeling and Linkage Agents for Immunoassays and Gene Probes
|
April 2006 |
£2410 |
10.15 % |
Market for Bioengineered Protein Drugs; The
|
January 2007 |
£2410 |
9.8 % |
Biomarkers
The Expanding Global Market
|
November 2007 |
£2410 |
9.8 % |
Gene Expression Profiling Markets
|
January 2008 |
£2015 |
9.8 % |
Proteomics
Technologies, Markets and Companies
|
March 2008 |
£1740 |
9.1 % |
RNAi
Technologies, Markets and Companies
|
March 2008 |
£1490 |
8.75 % |
Impact of Genomics on Clinical Trials and Medical Practice, The
|
April 2006 |
£1845 |
8.75 % |
Personalized Medicine
Scientific & Commercial Aspects
|
March 2008 |
£1740 |
8.75 % |
High Throughput Screening
|
January 2008 |
£1525 |
8.4 % |
Siemens Medical Solutions Medical Device Company Intelligence Report
|
February 2007 |
£395 |
8.05 % |
Biomarkers
Technologies, Markets and Companies
|
March 2008 |
£1515 |
8.05 % |
Global Market for Point of Care Diagnostics; The
|
December 2007 |
£695 |
8 % |
Protein Therapeutics Market; The
The Science and Business of a Growing Sector
|
June 2006 |
£1970 |
7.35 % |
Cardiac Marker Diagnostic Testing Markets
|
May 2008 |
£1715 |
7.35 % |
Molecular Diagnostics
Technologies, Markets and Companies
|
March 2008 |
£1985 |
7.35 % |
hERG Screening
|
January 2008 |
£1465 |
7 % |
Cancer Cell Therapy Markets
|
March 2008 |
£1690 |
7 % |
The Executive Guide to Molecular Imaging
|
July 2007 |
£595 |
7 % |
The Decentralized Diagnostic Testing Markets Business Challenges And Marketing Strategies
|
January 2008 |
£9830 |
5.95 % |
Stem Cell Research
|
January 2008 |
£2110 |
5.95 % |
Nanobiotechnology
|
March 2008 |
£1740 |
5.25 % |
Apoptosis
|
January 2008 |
£1440 |
5.25 % |
Blood Banking and Blood products
|
March 2008 |
£1995 |
4.55 % |
|
|
|
|
